Drain/inj joint/bursa w/o us
CPT code 20610 covers draining fluid from or injecting medication into a major joint (like a knee or shoulder) or bursa without using ultrasound guidance. This is a common outpatient procedure for treating conditions like arthritis, bursitis, or joint effusions.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Verify site-of-service coding accuracy: Non-facility (office) rate is $63.40 vs. facility rate $43.99. The provider receives the lower rate when performed in hospital outpatient or ASC settings.
Impact: Incorrect POS code costs $19.41 per procedure (44% reduction). For practices performing 200 injections yearly, this represents $3,882 in lost revenue.
Bill for the medication/drug separately using J-codes (e.g., J1030 for methylprednisolone, J7321-J7327 for hyaluronic acid). CPT 20610 covers only the procedure, not the injectable agent.
Impact: Medication can represent $15-$500+ additional reimbursement depending on the agent. Hyaluronic acid injections (J-codes) can exceed $200 per injection.
When billing multiple joint injections on the same date, list the highest-valued joint first without modifier, then append modifier 59 to subsequent injections of different anatomic sites. Some payers apply multiple procedure reductions.
Impact: Improper sequencing can trigger unnecessary reductions. Some payers reduce second injection by 50%, potentially reducing reimbursement by $21.99-$31.70 per additional injection.
Document whether aspiration, injection, or both were performed. Include joint/bursa site, laterality, volume aspirated (if any), character of fluid, medication injected, dosage, and medical necessity for the procedure.
Impact: Missing documentation elements are the leading cause of denials. Recovery rate for appeals with incomplete documentation is below 30%, costing the full $43.99-$63.40 per denial.
For modifier 25 claims, ensure the E/M note clearly documents a separately identifiable service beyond the decision to inject. Document that the problem was evaluated, history taken, exam performed, and decision-making occurred independent of the injection.
Modifier 25 denials occur in 20-30% of claims without proper documentation. Successfully supporting modifier 25 adds $50-$150 per encounter depending on E/M level billed.
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.